About
NeuroPace develops and commercializes the RNS System, an FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity. This system is designed for adults with drug-resistant focal epilepsy, offering significant seizure reduction and improved quality of life through personalized stimulation and data-driven insights for physicians.
Tags
Total Employees
248
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does NeuroPace do?
NeuroPace develops and commercializes the RNS System, an FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity. This system is designed for adults with drug-resistant focal epilepsy, offering significant seizure reduction and improved quality of life through personalized stimulation and data-driven insights for physicians.
How much funding has NeuroPace raised?
NeuroPace has raised a total of $475M in funding. The most recent round on record is IPO.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, United States.
When was NeuroPace founded?
NeuroPace was founded in 1997.
What industry does NeuroPace operate in?
NeuroPace operates in MedTech, HealthTech, Brain-Computer Interface, Non-Invasive BCI, Neurotech, HCI.
How many employees does NeuroPace have?
NeuroPace has approximately 248 people on record.